
Gustavo A. Balanza
Articles
-
Mar 29, 2023 |
nature.com | Fangyun Tian |David Zhou |Gustavo A. Balanza |Angelique C. Paulk |Rina Zelmann |Noam Peled | +5 more
AbstractKetamine produces antidepressant effects in patients with treatment-resistant depression, but its usefulness is limited by its psychotropic side effects. Ketamine is thought to act via NMDA receptors and HCN1 channels to produce brain oscillations that are related to these effects.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →